Loading…
Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas
The evaluation of the isocitrate dehydrogenase (IDH) mutation status in the glioma decision-making process has diagnostic, prognostic and therapeutic implications. The aim of this study was to evaluate whether conventional magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) can...
Saved in:
Published in: | Diagnostics (Basel) 2020-04, Vol.10 (4), p.247 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c565t-ac3f73f21ed1ec8357bc329c3dcec16f3b43419bf04156266ed63a1f277797493 |
---|---|
cites | cdi_FETCH-LOGICAL-c565t-ac3f73f21ed1ec8357bc329c3dcec16f3b43419bf04156266ed63a1f277797493 |
container_end_page | |
container_issue | 4 |
container_start_page | 247 |
container_title | Diagnostics (Basel) |
container_volume | 10 |
creator | Feraco, Paola Bacci, Antonella Ferrazza, Patrizia van den Hauwe, Luc Pertile, Riccardo Girlando, Salvatore Barbareschi, Mattia Gagliardo, Cesare Morganti, Alessio Giuseppe Petralia, Benedetto |
description | The evaluation of the isocitrate dehydrogenase (IDH) mutation status in the glioma decision-making process has diagnostic, prognostic and therapeutic implications. The aim of this study was to evaluate whether conventional magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) can noninvasively predict the most common IDH mutational status (R132H) in GIII-astrocytomas and the overall survival (OS). Hence, twenty-two patients (9-F, 13-M) with a histological diagnosis of GIII-astrocytoma and evaluation of IDH-mutation status (12-wild type, 10-mutant) were retrospectively evaluated. Imaging studies were reviewed for the morphological feature and mean ADC values (ADCm). Statistics included a Fisher's exact test, Student's
-test, Spearman's Test and receiver operating characteristic analysis. A
≤ 0.05 value was considered statistically significant for all the tests. A younger age and a frontal location were more likely related to mutational status. IDH-wild type (Wt) exhibited a slight enhancement (
= 0.039). The ADCm values in IDH-mutant (Mut) patients were higher than those of IDH-Wt patients (
< 0.0004). The value of ADC ≥ 0.99 × 10
mm
/s emerged as a "cut-off" to differentiate the mutation state. In the overall group, a positive relationship between the ADCm values and OS was detected (
= 0.003; r = 0.62). Adding quantitative measures of ADC values to conventional MR imaging could be used routinely as a noninvasive marker of specific molecular patterns. |
doi_str_mv | 10.3390/diagnostics10040247 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f4d28ce48b13414cb66b72b5eb2c4872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_f4d28ce48b13414cb66b72b5eb2c4872</doaj_id><sourcerecordid>2395602840</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-ac3f73f21ed1ec8357bc329c3dcec16f3b43419bf04156266ed63a1f277797493</originalsourceid><addsrcrecordid>eNptkk9LHTEUxUNpqfLqJyiUQDfdPM2_SWY2BatWBxShtuuQydxM8zovscnMgN--0WdFS7O5ITn3xz3JQeg9JYecN-So92YIMU_eZkqIIEyoV2ifEVWthaD162f7PXSQ84aU1VBes-ot2uOMC8JpvY_yVeFAweBvkGMwwQJut2bwYcCnkPwCPf7i49akX5Ayjg63pxf4ap7M5GPAN6XOGZvQ4-sFkhlHfDOnxS9mxD7g82T6wmtbfJynFO3dVEj5HXrjzJjh4LGu0I-vZ99PLtaX1-ftyfHl2laymtbGcqe4YxR6CrbmleosZ43lvQVLpeOd4II2nSOCVpJJCb3khjqmlGqUaPgKtTtuH81G3yZfXNzpaLx-OIhp0CYV6yNoJ3pWWxB1RwtT2E7KTrGugo5ZUStWWJ93rNu520KZIEzF7Qvoy5vgf-ohLrr0SkJFAXx6BKT4e4Y86a3PFsbRBIhz1ow3lSSsLv-yQh__kW7inEJ5qgcVr6WU90C-U9kUc07gnoahRN9nRP8nI6Xrw3MfTz1_E8H_AARtutI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2395386664</pqid></control><display><type>article</type><title>Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Feraco, Paola ; Bacci, Antonella ; Ferrazza, Patrizia ; van den Hauwe, Luc ; Pertile, Riccardo ; Girlando, Salvatore ; Barbareschi, Mattia ; Gagliardo, Cesare ; Morganti, Alessio Giuseppe ; Petralia, Benedetto</creator><creatorcontrib>Feraco, Paola ; Bacci, Antonella ; Ferrazza, Patrizia ; van den Hauwe, Luc ; Pertile, Riccardo ; Girlando, Salvatore ; Barbareschi, Mattia ; Gagliardo, Cesare ; Morganti, Alessio Giuseppe ; Petralia, Benedetto</creatorcontrib><description>The evaluation of the isocitrate dehydrogenase (IDH) mutation status in the glioma decision-making process has diagnostic, prognostic and therapeutic implications. The aim of this study was to evaluate whether conventional magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) can noninvasively predict the most common IDH mutational status (R132H) in GIII-astrocytomas and the overall survival (OS). Hence, twenty-two patients (9-F, 13-M) with a histological diagnosis of GIII-astrocytoma and evaluation of IDH-mutation status (12-wild type, 10-mutant) were retrospectively evaluated. Imaging studies were reviewed for the morphological feature and mean ADC values (ADCm). Statistics included a Fisher's exact test, Student's
-test, Spearman's Test and receiver operating characteristic analysis. A
≤ 0.05 value was considered statistically significant for all the tests. A younger age and a frontal location were more likely related to mutational status. IDH-wild type (Wt) exhibited a slight enhancement (
= 0.039). The ADCm values in IDH-mutant (Mut) patients were higher than those of IDH-Wt patients (
< 0.0004). The value of ADC ≥ 0.99 × 10
mm
/s emerged as a "cut-off" to differentiate the mutation state. In the overall group, a positive relationship between the ADCm values and OS was detected (
= 0.003; r = 0.62). Adding quantitative measures of ADC values to conventional MR imaging could be used routinely as a noninvasive marker of specific molecular patterns.</description><identifier>ISSN: 2075-4418</identifier><identifier>EISSN: 2075-4418</identifier><identifier>DOI: 10.3390/diagnostics10040247</identifier><identifier>PMID: 32340318</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Age ; anaplastic astrocytomas ; apparent diffusion coefficient (ADC) ; Biomarkers ; Brain cancer ; Brownian motion ; Classification ; diffusion weighted imaging (DWI) ; Edema ; Histology ; isocitrate dehydrogenase (IDH) mutation ; Magnetic resonance imaging ; Mutation ; overall survival ; Patients ; radiogenomics ; Software ; Tumors ; Work stations</subject><ispartof>Diagnostics (Basel), 2020-04, Vol.10 (4), p.247</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-ac3f73f21ed1ec8357bc329c3dcec16f3b43419bf04156266ed63a1f277797493</citedby><cites>FETCH-LOGICAL-c565t-ac3f73f21ed1ec8357bc329c3dcec16f3b43419bf04156266ed63a1f277797493</cites><orcidid>0000-0003-1455-842X ; 0000-0003-0217-3223 ; 0000-0002-3707-018X ; 0000-0003-4088-2020</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2395386664/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2395386664?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,75096</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32340318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feraco, Paola</creatorcontrib><creatorcontrib>Bacci, Antonella</creatorcontrib><creatorcontrib>Ferrazza, Patrizia</creatorcontrib><creatorcontrib>van den Hauwe, Luc</creatorcontrib><creatorcontrib>Pertile, Riccardo</creatorcontrib><creatorcontrib>Girlando, Salvatore</creatorcontrib><creatorcontrib>Barbareschi, Mattia</creatorcontrib><creatorcontrib>Gagliardo, Cesare</creatorcontrib><creatorcontrib>Morganti, Alessio Giuseppe</creatorcontrib><creatorcontrib>Petralia, Benedetto</creatorcontrib><title>Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas</title><title>Diagnostics (Basel)</title><addtitle>Diagnostics (Basel)</addtitle><description>The evaluation of the isocitrate dehydrogenase (IDH) mutation status in the glioma decision-making process has diagnostic, prognostic and therapeutic implications. The aim of this study was to evaluate whether conventional magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) can noninvasively predict the most common IDH mutational status (R132H) in GIII-astrocytomas and the overall survival (OS). Hence, twenty-two patients (9-F, 13-M) with a histological diagnosis of GIII-astrocytoma and evaluation of IDH-mutation status (12-wild type, 10-mutant) were retrospectively evaluated. Imaging studies were reviewed for the morphological feature and mean ADC values (ADCm). Statistics included a Fisher's exact test, Student's
-test, Spearman's Test and receiver operating characteristic analysis. A
≤ 0.05 value was considered statistically significant for all the tests. A younger age and a frontal location were more likely related to mutational status. IDH-wild type (Wt) exhibited a slight enhancement (
= 0.039). The ADCm values in IDH-mutant (Mut) patients were higher than those of IDH-Wt patients (
< 0.0004). The value of ADC ≥ 0.99 × 10
mm
/s emerged as a "cut-off" to differentiate the mutation state. In the overall group, a positive relationship between the ADCm values and OS was detected (
= 0.003; r = 0.62). Adding quantitative measures of ADC values to conventional MR imaging could be used routinely as a noninvasive marker of specific molecular patterns.</description><subject>Age</subject><subject>anaplastic astrocytomas</subject><subject>apparent diffusion coefficient (ADC)</subject><subject>Biomarkers</subject><subject>Brain cancer</subject><subject>Brownian motion</subject><subject>Classification</subject><subject>diffusion weighted imaging (DWI)</subject><subject>Edema</subject><subject>Histology</subject><subject>isocitrate dehydrogenase (IDH) mutation</subject><subject>Magnetic resonance imaging</subject><subject>Mutation</subject><subject>overall survival</subject><subject>Patients</subject><subject>radiogenomics</subject><subject>Software</subject><subject>Tumors</subject><subject>Work stations</subject><issn>2075-4418</issn><issn>2075-4418</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk9LHTEUxUNpqfLqJyiUQDfdPM2_SWY2BatWBxShtuuQydxM8zovscnMgN--0WdFS7O5ITn3xz3JQeg9JYecN-So92YIMU_eZkqIIEyoV2ifEVWthaD162f7PXSQ84aU1VBes-ot2uOMC8JpvY_yVeFAweBvkGMwwQJut2bwYcCnkPwCPf7i49akX5Ayjg63pxf4ap7M5GPAN6XOGZvQ4-sFkhlHfDOnxS9mxD7g82T6wmtbfJynFO3dVEj5HXrjzJjh4LGu0I-vZ99PLtaX1-ftyfHl2laymtbGcqe4YxR6CrbmleosZ43lvQVLpeOd4II2nSOCVpJJCb3khjqmlGqUaPgKtTtuH81G3yZfXNzpaLx-OIhp0CYV6yNoJ3pWWxB1RwtT2E7KTrGugo5ZUStWWJ93rNu520KZIEzF7Qvoy5vgf-ohLrr0SkJFAXx6BKT4e4Y86a3PFsbRBIhz1ow3lSSsLv-yQh__kW7inEJ5qgcVr6WU90C-U9kUc07gnoahRN9nRP8nI6Xrw3MfTz1_E8H_AARtutI</recordid><startdate>20200423</startdate><enddate>20200423</enddate><creator>Feraco, Paola</creator><creator>Bacci, Antonella</creator><creator>Ferrazza, Patrizia</creator><creator>van den Hauwe, Luc</creator><creator>Pertile, Riccardo</creator><creator>Girlando, Salvatore</creator><creator>Barbareschi, Mattia</creator><creator>Gagliardo, Cesare</creator><creator>Morganti, Alessio Giuseppe</creator><creator>Petralia, Benedetto</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1455-842X</orcidid><orcidid>https://orcid.org/0000-0003-0217-3223</orcidid><orcidid>https://orcid.org/0000-0002-3707-018X</orcidid><orcidid>https://orcid.org/0000-0003-4088-2020</orcidid></search><sort><creationdate>20200423</creationdate><title>Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas</title><author>Feraco, Paola ; Bacci, Antonella ; Ferrazza, Patrizia ; van den Hauwe, Luc ; Pertile, Riccardo ; Girlando, Salvatore ; Barbareschi, Mattia ; Gagliardo, Cesare ; Morganti, Alessio Giuseppe ; Petralia, Benedetto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-ac3f73f21ed1ec8357bc329c3dcec16f3b43419bf04156266ed63a1f277797493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>anaplastic astrocytomas</topic><topic>apparent diffusion coefficient (ADC)</topic><topic>Biomarkers</topic><topic>Brain cancer</topic><topic>Brownian motion</topic><topic>Classification</topic><topic>diffusion weighted imaging (DWI)</topic><topic>Edema</topic><topic>Histology</topic><topic>isocitrate dehydrogenase (IDH) mutation</topic><topic>Magnetic resonance imaging</topic><topic>Mutation</topic><topic>overall survival</topic><topic>Patients</topic><topic>radiogenomics</topic><topic>Software</topic><topic>Tumors</topic><topic>Work stations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feraco, Paola</creatorcontrib><creatorcontrib>Bacci, Antonella</creatorcontrib><creatorcontrib>Ferrazza, Patrizia</creatorcontrib><creatorcontrib>van den Hauwe, Luc</creatorcontrib><creatorcontrib>Pertile, Riccardo</creatorcontrib><creatorcontrib>Girlando, Salvatore</creatorcontrib><creatorcontrib>Barbareschi, Mattia</creatorcontrib><creatorcontrib>Gagliardo, Cesare</creatorcontrib><creatorcontrib>Morganti, Alessio Giuseppe</creatorcontrib><creatorcontrib>Petralia, Benedetto</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Diagnostics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feraco, Paola</au><au>Bacci, Antonella</au><au>Ferrazza, Patrizia</au><au>van den Hauwe, Luc</au><au>Pertile, Riccardo</au><au>Girlando, Salvatore</au><au>Barbareschi, Mattia</au><au>Gagliardo, Cesare</au><au>Morganti, Alessio Giuseppe</au><au>Petralia, Benedetto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas</atitle><jtitle>Diagnostics (Basel)</jtitle><addtitle>Diagnostics (Basel)</addtitle><date>2020-04-23</date><risdate>2020</risdate><volume>10</volume><issue>4</issue><spage>247</spage><pages>247-</pages><issn>2075-4418</issn><eissn>2075-4418</eissn><abstract>The evaluation of the isocitrate dehydrogenase (IDH) mutation status in the glioma decision-making process has diagnostic, prognostic and therapeutic implications. The aim of this study was to evaluate whether conventional magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) can noninvasively predict the most common IDH mutational status (R132H) in GIII-astrocytomas and the overall survival (OS). Hence, twenty-two patients (9-F, 13-M) with a histological diagnosis of GIII-astrocytoma and evaluation of IDH-mutation status (12-wild type, 10-mutant) were retrospectively evaluated. Imaging studies were reviewed for the morphological feature and mean ADC values (ADCm). Statistics included a Fisher's exact test, Student's
-test, Spearman's Test and receiver operating characteristic analysis. A
≤ 0.05 value was considered statistically significant for all the tests. A younger age and a frontal location were more likely related to mutational status. IDH-wild type (Wt) exhibited a slight enhancement (
= 0.039). The ADCm values in IDH-mutant (Mut) patients were higher than those of IDH-Wt patients (
< 0.0004). The value of ADC ≥ 0.99 × 10
mm
/s emerged as a "cut-off" to differentiate the mutation state. In the overall group, a positive relationship between the ADCm values and OS was detected (
= 0.003; r = 0.62). Adding quantitative measures of ADC values to conventional MR imaging could be used routinely as a noninvasive marker of specific molecular patterns.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32340318</pmid><doi>10.3390/diagnostics10040247</doi><orcidid>https://orcid.org/0000-0003-1455-842X</orcidid><orcidid>https://orcid.org/0000-0003-0217-3223</orcidid><orcidid>https://orcid.org/0000-0002-3707-018X</orcidid><orcidid>https://orcid.org/0000-0003-4088-2020</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2075-4418 |
ispartof | Diagnostics (Basel), 2020-04, Vol.10 (4), p.247 |
issn | 2075-4418 2075-4418 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_f4d28ce48b13414cb66b72b5eb2c4872 |
source | Publicly Available Content (ProQuest); PubMed Central |
subjects | Age anaplastic astrocytomas apparent diffusion coefficient (ADC) Biomarkers Brain cancer Brownian motion Classification diffusion weighted imaging (DWI) Edema Histology isocitrate dehydrogenase (IDH) mutation Magnetic resonance imaging Mutation overall survival Patients radiogenomics Software Tumors Work stations |
title | Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A22%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Magnetic%20Resonance%20Imaging%20Derived%20Biomarkers%20of%20IDH%20Mutation%20Status%20and%20Overall%20Survival%20in%20Grade%20III%20Astrocytomas&rft.jtitle=Diagnostics%20(Basel)&rft.au=Feraco,%20Paola&rft.date=2020-04-23&rft.volume=10&rft.issue=4&rft.spage=247&rft.pages=247-&rft.issn=2075-4418&rft.eissn=2075-4418&rft_id=info:doi/10.3390/diagnostics10040247&rft_dat=%3Cproquest_doaj_%3E2395602840%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c565t-ac3f73f21ed1ec8357bc329c3dcec16f3b43419bf04156266ed63a1f277797493%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2395386664&rft_id=info:pmid/32340318&rfr_iscdi=true |